Can VEGF reverse diabetic neuropathy in human subjects?
Veves
A
A
Microcirculation Lab, Beth Israel Deaconess Medical Center, and. Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
King
G L
GL
D003929:Diabetic Neuropathies / Q000188:drug therapy* / Q000209:etiology; D016228:Endothelial Growth Factors / Q000627:therapeutic use*; D006801:Humans; D008222:Lymphokines / Q000627:therapeutic use*; D008833:Microcirculation / Q000473:pathology; D010525:Peripheral Nerves / Q000473:pathology; D014650:Vasa Nervorum / Q000473:pathology; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors